Cargando…
Discovery of a natural small-molecule AMP-activated kinase activator that alleviates nonalcoholic steatohepatitis
Non-alcoholic steatohepatitis (NASH) is a primary cause of cirrhosis and hepatocellular carcinoma. Unfortunately, there is no approved drug treatment for NASH. AMP-activated kinase (AMPK) is an important metabolic sensor and whole-body regulator. It has been proposed that AMPK activators could be us...
Autores principales: | Chen, Jin, Xu, Li, Zhang, Xue-Qing, Liu, Xue, Zhang, Zi-Xuan, Zhu, Qiu-Mei, Liu, Jian-Yu, Iqbal, Muhammad Omer, Ding, Ning, Shao, Chang-Lun, Wei, Mei-Yan, Gu, Yu-Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232707/ https://www.ncbi.nlm.nih.gov/pubmed/37275542 http://dx.doi.org/10.1007/s42995-023-00168-z |
Ejemplares similares
-
Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP‐Activated Protein Kinase Signaling Pathway
por: Lan, Tian, et al.
Publicado: (2021) -
Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
por: Noureddin, Mazen, et al.
Publicado: (2019) -
Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis
por: Chen, Hui, et al.
Publicado: (2022) -
Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis
por: Ganbold, Munkhzul, et al.
Publicado: (2019) -
15-keto-PGE(2) alleviates nonalcoholic steatohepatitis through its covalent modification of NF-κB factors
por: Hee, Siow-Wey, et al.
Publicado: (2023)